Security key
107930109
- Security type / class
- Equity / NULL
- Total 13F shares
- 2,040,376
- Total 13F value
- $5,800,763
- Share change
- -349,308
- Put/Call ratio
- 9%
- SEC-reported price per share
- $2.86
- Number of holders
- 16
- Value change
- -$1,947,798
- Number of buys
- 8
- Number of sells
- 11
Open additional details 1 more signal available
Report period
Q1 2024
Institutions
16
Top holders
10
BCTX full security history
Ownership snapshot
Full 13F holder table
BriaCell Therapeutics Corp. SEC filings
BriaCell Therapeutics Corp. company facts
Broader feeds
Ownership snapshot
Top reported holders of BCTX - BriaCell Therapeutics Corp. - NULL (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Lynwood Capital Managemen...
Disclosed value leader
Lynwood Capital Managemen...
Comparable rows
0/15
Latest evidence
31 Dec 2023
13F
3/4/5
Highest disclosed value: $9,246,773
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Lynwood Capital Management Inc. has the largest disclosed position value at $9.25M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Lynwood Capital Management Inc.'s linked filing trail.
Disclosed position value
Top 5
Lynwood Capital Management Inc.
$9.25M
WASATCH ADVISORS LP
$1.56M
Redmond Asset Management, LLC
$968.9K
ARMISTICE CAPITAL, LLC
$937.5K
Jamieson Bondarenko
$777.9K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Lynwood Capital Management Inc. |
13F
Company
|
—
denominator unverified
|
$9,246,773
1,580,645 shares
|
— | 31 Dec 2023 |
| WASATCH ADVISORS LP |
13F
Company
|
—
denominator unverified
|
$1,564,349
267,410 shares
|
— | 31 Dec 2023 |
| Redmond Asset Management, LLC |
13F
Company
|
—
mixed-class rows
|
$968,879
208,569 shares
mixed-class rows
|
— | 31 Dec 2023 |
| ARMISTICE CAPITAL, LLC |
13F
Company
|
—
denominator unverified
|
$937,500
375,000 shares
|
— | 31 Dec 2023 |
| Jamieson Bondarenko |
3/4/5
Chairman, Director
|
—
denominator unverified
|
$777,940
169,856 shares
|
— | 28 Dec 2022 |
| K.J. Harrison & Partners Inc |
13F
Company
|
—
denominator unverified
|
$476,015
80,715 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
16
Shares
2,040,376
Rows available
16
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2024 Across Filers
Q1 2024 holders
16
Q1 2024 holders
16
Holder diff
0
| Investor | Q1 2024 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q1 2024 value | Value change | Value Chg % |
|---|